Topics

COAPT: MitraClip Adds Years of Life, but at a Steep Price

12:00 EDT 4 Oct 2019 | Medscape

Cumulative 2-year costs were higher with the device than medical therapy but, overall, the cost-effectiveness is comparable with other commonly used heart failure treatments.
Medscape Medical News

Original Article: COAPT: MitraClip Adds Years of Life, but at a Steep Price

NEXT ARTICLE

More From BioPortfolio on "COAPT: MitraClip Adds Years of Life, but at a Steep Price"

Quick Search